ClinicalTrials.Veeva

Menu

Study of Tomotherapy HD in Medulloblastoma

Shanghai Jiao Tong University logo

Shanghai Jiao Tong University

Status

Unknown

Conditions

Medulloblastoma

Treatments

Device: 3DCRT
Device: Tomotherapy HD

Study type

Interventional

Funder types

Other

Identifiers

NCT03675230
XH-18-012

Details and patient eligibility

About

The aim of the study was to improve local control and long-term survival in children with medulloblastoma, reduce the side effects of treatment and improve quality of life.

Full description

The technical advantages of Tomotherapy HD in the radiotherapy of children medulloblastoma (advantages in clinical operation and physics) were transformed into clinical advantages, and the possible mechanisms were explored.

Enrollment

220 estimated patients

Sex

All

Ages

3 to 12 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patient was diagnosed as myeloblastoma by surgical pathology with definite pathological classification. MRI of the head and spinal cord before and after operation, with definite staging; Radiotherapy was performed within 28 days after surgery.

Exclusion criteria

  • Previous radiotherapy in the whole brain, whole spinal cord or primary focus; Postoperative radiotherapy for more than 28 days.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

220 participants in 2 patient groups

3DCRT
Active Comparator group
Description:
This arm will be planned by 3DCRT to the treatment of the Medulloblastoma
Treatment:
Device: 3DCRT
Tomotherapy HD,TOMO
Experimental group
Description:
This arm will be planned by TOMO to the treatment of the Medulloblastoma
Treatment:
Device: Tomotherapy HD

Trial contacts and locations

1

Loading...

Central trial contact

chuanying zhu, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems